Patient leaflet - Teriparatide Biotech 20 micrograms/80 microlitres solution for injection in Pre-filled pen
1. What Teriparatide Biotech is and what it is used for
Teriparatide Biotech contains the active
substance teriparatide that is used to
make the bones stronger and to reduce
the risk of fractures by stimulating bone
formation.
Teriparatide Biotech is used to treat
osteoporosis in adults. Osteoporosis is a
disease that causes your bones to
become thin and fragile. This disease is
especially common in women after the
menopause, but it can also occur in
men. Osteoporosis is also common in
patients receiving corticosteroids.
2. What you need to know before you use Teriparatide Biotech
Do not use Teriparatide Biotech
if you are allergic to teriparatide or
any of the other ingredients of this
medicine (listed in section 6).
if you suffer from high calcium levels
(pre-existing hypercalcaemia).
if you suffer from serious kidney
problems.
if you have ever been diagnosed with
bone cancer or other cancers that
have spread (metastasised) to your
bones.
Teriparatide Biotech 20 micrograms/ 80 microlitres solution for injection in pre-filled pen
Teriparatide
Package leaflet: Information for the user
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
- Keep this leaflet. You may need to read it again.
- If you have any further questions, ask your doctor or pharmacist.
- This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.
- if you have certain bone diseases. If you have a bone disease, tell your doctor.
- if you have unexplained high levels of alkaline phosphatase in your blood, which means you might have Paget’s disease of bone (disease with abnormal bone changes). If you are not sure, ask your doctor.
- if you have had radiation therapy involving your bones.
- if you are pregnant or breast-feeding
Warning and precautions
Teriparatide Biotech may cause an increase in the amount of calcium in your blood or urine.
Talk to your doctor or pharmacist before or while using Teriparatide Biotech:
- if you have continuing nausea, vomiting, constipation, low energy, or muscle weakness. These may be signs there is too much calcium in your blood.
- if you suffer from kidney stones or have a history of kidney stones.
- if you suffer from kidney problems (moderate renal impairment).
Some patients get dizzy or get a fast heartbeat after the first few doses. For the first doses, inject Teriparatide Biotech where you can sit or lie down right away if you get dizzy.
The recommended treatment time of 24 months should not be exceeded.
Teriparatide Biotech should not be used in growing adults.
Children and adolescents
Teriparatide Biotech should not be used in children and adolescents (less than 18 years).
Other medicines and Teriparatide Biotech
Please tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines because occasionally they may interact (e.g. digoxin/digitalis, a medicine used to treat heart disease).
Pregnancy and breast-feeding
Do not use Teriparatide Biotech if you are pregnant or breast-feeding. If you are a woman of child-bearing potential, you should use effective methods of contraception during use of Teriparatide Biotech.
If you become pregnant, Teriparatide Biotech should be discontinued. Ask your doctor or pharmacist for advice before taking any medicine.
Driving and using machines
Some patients may feel dizzy after injecting Teriparatide Biotech. If you feel dizzy you should not drive or use machines until you feel better.
Important information about some of the ingredients of Teriparatide Biotech
This medicine contains less than 1 mmol sodium (23 mg) per dose. This means that it is essentially “sodium-free”.
3. How to use Teriparatide Biotech
Always use this medicine exactly as your doctor has told you to. Check with your doctor or pharmacist if you are not sure.
The recommended dose is 20 micrograms given once daily by injection under the skin (subcutaneous injection) in the thigh or abdomen. To help you remember to take your medicine, inject it at about the same time each day.
Inject Teriparatide Biotech each day for as long as your doctor prescribes it for you. The total duration of treatment with Teriparatide Biotech should not exceed 24 months. You should not receive more than one treatment course of 24 months over your lifetime. Teriparatide Biotech can be injected at meal times.
Read the user manual booklet, which is included in the carton for instructions on how to use the Teriparatide Biotech pen
Injection needles are not included with the pen. Becton, Dickinson and
Company pen needles can be used.
You should take your Teriparatide Biotech injection shortly after you take the pen out of the refrigerator as described in the user manual. Put the pen back into the refrigerator immediately after you have used it. Use a new injection needle for each injection and dispose of it after each use. Never store your pen with the needle attached. Never share your Teriparatide Biotech pen with others.
Your doctor may advise you to take Teriparatide Biotech with calcium and vitamin D.
Your doctor will tell you how much you should take each day.
Teriparatide Biotech can be given with or without food.
If you use more of Teriparatide Biotech than you should
If, by mistake, you have used more Teriparatide Biotech than you should, contact your doctor or pharmacist. The effects of overdose that might be expected include nausea, vomiting, dizziness, and headache.
If you forget or cannot take Teriparatide Biotech at your usual time, take it as soon as possible on that day. Do not take a double dose to make up for a forgotten dose. Do not take more than one injection in the same day. Do not try to make up for a missed dose.
If you stop taking Teriparatide Biotech
If you are considering stopping Teriparatide Biotech treatment, please discuss this with your doctor. Your doctor will advise you and decide how long you should be treated with Teriparatide Biotech.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
The most common side effects are pain in the limbs (frequency is very common: may affect more than 1 in 10 people) and feeling sick, headache and dizziness (frequency is common). If you become Biotech Pharma Limited Manufacturer
Teriparatide Biotech 20mcg/80µL solution - PIL
Formatting Criteria Teriparatide Biotech 20mcg/80µL solution
Single Page Dimensions
Number of Pages
Font Style
280 (W) x 270 (H)
Frutiger LT Std
15.5 pt
11 pt
9 pt
dizzy (light-headed) after your injection, you should sit or lie down until you feel better. If you do not feel better, you should call a doctor before you continue treatment. Cases of fainting have been reported in association with teriparatide use.
If you experience discomfort such as redness of the skin, pain, swelling, itching, bruising or minor bleeding around the area of the injection (frequency is common), this should clear up in a few days or weeks. Otherwise tell your doctor as soon as possible.
Some patients may have experienced allergic reactions soon after injection, consisting of breathlessness, swelling of the face, rash and chest pain (frequency is rare). In rare cases, serious and potentially life-threatening allergic reactions including anaphylaxis can occur.
Other side effects include:
Common: may affect up to 1 in 10 people
- increase in blood cholesterol levels
- depression
- neuralgic pain in the leg
- feeling faint
- irregular heart beats
- breathlessness
- increased sweating
- muscle cramps
- loss of energy
- tiredness
- chest pain
- low blood pressure
- heartburn (painful or burning sensation just below the breast bone)
- being sick (vomiting)
- a hernia of the tube that carries food to your stomach
- low haemoglobin or red blood cell count (anaemia)
Uncommon: may affect up to 1 in 100 people
- increased heart rate
- abnormal heart sound
- shortness of breath
- haemorrhoids (piles)
- accidental loss or leakage of urine
- increased need to pass water
- weight increase
- kidney stones
pain in the muscles and pain in the joints. Some patients have
experienced severe back cramps or pain, which led to hospitalisation.
- increase in blood calcium level
increase in blood uric acid level
- increase in an enzyme called alkaline phosphatase.
Rare: may affect up to 1 in 1,000 people
- reduced kidney function, including renal failure
- swelling, mainly in the hands, feet and legs.
Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow card Scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects, you can help provide more information on the safety of this medicine.
5. How to store Teriparatide Biotech
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and pen after EXP. The expiry date refers to the last day of that month.
Teriparatide Biotech should be stored in a refrigerator (2°C to 8°C) at all times. You can use the pen for up to 28 days after the first injection, as long as the pen is stored in a refrigerator (2°C to 8°C).
Do not freeze Teriparatide Biotech. Avoid placing the pens close to the ice compartment of the refrigerator to prevent freezing. Do not use the pen if it is, or has been, frozen.
Each pen should be properly disposed of after 28 days, even if it is not completely empty.
Teriparatide Biotech contains a clear and colorless solution. Do not use Teriparatide Biotech if solid particles appear or if the solution is cloudy or coloured.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.
6. Contents of the pack and other information
What Teriparatide Biotech contains
- The active substance is teriparatide. Each ml of the solution for injection contains 250 micrograms of teriparatide.
- The other ingredients are glacial acetic acid, sodium acetate, mannitol, metacresol, and water for injections. In addition, hydrochloric acid and/or sodium hydroxide solution may have been added for pH adjustment.
What Teriparatide Biotech looks like and contents of the pack
Teriparatide Biotech is a colorless and clear solution. It is supplied in a cartridge contained in a pre -filled disposable pen. Each pen contains 2.4 ml of solution enough for 28 doses. The pens are available in cartons containing 1 or 3 pens. Not all pack sizes may be available.
Marketing Authorisation Holder
Biotech Pharma Limited
Quantum House, Hobson,
Newcastle Upon Tyne, NE16 6EA, United Kingdom
Manufacturer
GP-PHARM, S.A.
Polígono Industrial Els Vinyets-Els Fogars, Sector 2, Carretera Comarcal C-244, Km 22 08777 Sant Quintí de Mediona Spain
This leaflet was last revised in 06/2025
Teriparatide Biotech Parts*
- 1. pen cap
- 2. cartridge with medicine
- 3. label
- 4. dose window
- 5. dose knob
- 6. dose activator
- 7. large outer cap
- 8. small inner cap
- 9. needle
- 10. seal foil
* Needles are not included.
Becton, Dickinson and Company pen needles can be used. Ask your doctor or pharmacist which needle gauge and length are best for you.
For your safety
Prevention of infectious diseases
Do not share your pen as this may risk the
transmission of infectious diseases.
- Use a new sterile needle for each injection.
Put used needles in a sharps container or a hard
plastic container with a secure lid. Do not throw needles directly into your household waste.
Use of the pen
Check the pen label when taking the pen out of
the refrigerator. Ensure that you use the right medicine.
Check the expiry date. Do not use the pen if it
has expired.
Check the medicine. It must be clear, colourless
and free of particles.
Do not transfer the medicine to a syringe. It
must be administered using this pen only.
Do not use the pen for more than 28 injections.
Diary on the back of these Instructions for Use. Calculate the date for the 28th injection by using a calendar and make a note of this date in the Injection Diary.
The pen is not recommended for use by the
blind or visually impaired without help from a person who is trained in the proper use of the device.
Storage
Keep the pen in the refrigerator, preferably in
the door compartment.
Keep the pen and needles out of the sight and
reach of children.
Troubleshooting
If you have a problem with the injection, do not
give a second injection on the same day.
Read the section “What to do if...” in these
Instructions for Use.
- Do not use the pen if it is damaged.
Only use the pen if the medicine is clear,
colourless and free of particles.
If you cannot solve the problem by yourself
or if you are uncertain, contact your doctor, pharmacist, nurse or carer.
Follow these instructions every time you prepare a
You only have to perform this step once. You do NOT need to repeat this step for the second, third or any further injections.
Attaching the needle
- 1. Remove the pen cap.
- 2.
Take a new needle and remove the seal foil from
the large outer cap.
- 3.
Attach the needle with the large outer cap to
the pen. Screw the large outer cap clockwise as far as it will go.
- 4.
Remove the large outer cap from the needle and
save it.
Dialling the Dose
- 5.
Turn the dose knob clockwise to the hard stop
(until it cannot be rotated any further). Make in the dose window. The white mark and the window notch should be aligned.
- 6. Remove the small inner cap from the needle and throw away.
- 7. Hold the pen with the needle up. Push the dose activator as far as it will go (to the hard stop) and hold for 5 seconds. Collect the expelled liquid with a tissue.
- 8. Check that the display reads “0” and that this window, the white mark and the window notch are aligned, and the dose knob and pen body marks are aligned.
- 5.
Removing the Needle
Remove the needle after preparation of the pen, to minimise the risk of infection.
- 9. Carefully push the needle into the large outer cap. Do not touch the needle.
- 10. Unscrew the needle by turning the large outer cap anti-clockwise and pull the needle from the pen.
- 11. Dispose of the needle (in the needle cap) in a sharps container or a hard plastic container with a secure lid as directed by your doctor or pharmacist (see “For your safety” above).
Keeping the Injection Diary
- 12. Note the current date and the date of the 28th injection in the Injection Diary on the back of these instructions for use.
further injections as described below.
Injecting the Pen
Prepare yourself for injection
- Wash your hands before every injection.
- Prepare the injection site (on the thigh or abdomen) as directed by your doctor, pharmacist or carer.
Use a new needle for every injection. A used needle poses a risk of infection.
Attaching the needle
- 1. Remove the pen cap.
- 2. Take a new needle and remove the seal foil from the needle cap.
- 3. Attach the needle with the large outer cap to the pen. Screw the large outer cap clockwise as far as it will go.
- 4. Remove the large outer cap from the needle and save it.
Pen User Manual
Instructions for use
Before you use your new pen, please read these instructions carefully. Follow the directions carefully when using the pen.
Your pen contains 28 days of medicine.
5 s
Teriparatide Biotech 20 micrograms/80 microlitres solution for injection in pre-filled pen
Biotech Pharma Limited Manufacturer
Formatting Criteria Teriparatide Biotech 20mcg/80µL solution
Single Page Dimensions
Number of Pages
Font Style
180 (W) x 560 (H)
Frutiger LT Std
18 pt
10 pt
9 pt
Dialling the Dose
- 5.
Turn the dose knob clockwise to the hard stop
(until it cannot be rotated any further). Make
in the dose window. The white mark and the window notch should be aligned.
- 6.
Remove the small inner cap from the needle and
throw away.
- 7.
Select an appropriate injection site and prepare
your skin as recommended by your doctor. Gently hold a fold of skin from your thigh or
- 8.
Insert the needle, preferably at a 90 degree
angle at the prepared injection site. Push the dose activator as far as it will go (to the hard stop) and hold for 5 seconds. Count slowly to 5.
- 9. Pull out the needle from the skin.
- 10.
Check that the display reads “0”and that this
window, the white mark and the window notch are aligned, and the dose knob and pen body marks are aligned.
Removing the needle
Always remove the needle immediately after the pen has been used.
- 11.
Carefully push the needle into the large outer
cap. Do not touch the needle.
- 12.
Unscrew the needle by turning the large outer cap
anti-clockwise and pull the needle from the pen.
- 13.
Dispose of the needle (in its large outer cap) in
a sharps container or a hard plastic container with a secure lid, as directed by your doctor or pharmacist.
- 14. Re-attach the pen cap to the pen.
Storing the pen
Do not store the pen with a needle attached.
Doing this may cause air bubbles to form in the medicine cartridge. Always close the pen with the pen cap.
Store the pen in the refrigerator, preferably
in the door compartment. Do not store it next to the back wall of the refrigerator or in the freezer. The medicine becomes unusable if frozen.
If your pen has been left out of the refrigerator,
do not throw the pen away. Put it back in the refrigerator and contact your doctor or pharmacist.
Disposing of the pen
Before throwing away the pen, be sure to
remove the needle and attach the pen cap.
Throw away your pen and used needles in a
sharps container or a hard plastic container with a secure lid, as directed by your doctor or pharmacist.
•
What to do if….
You can see an air bubble in the cartridge: You can continue to use your pen as usual.
medicine is expelled: Perform the steps as described in “Dialling the dose” again (page 5).
The dose activator is blocked or you think you may not have injected the full dose: Do not give a second injection the same day. Proceed with your regular injection the next day. Make sure you
“80” is fully visible and centred in the dose window with the white mark aligned in the window notch.
Injection Diary
Manufacturer
Date of last injection day 28
This user manual was last revised in 06/2025
5 s
Biotech Pharma Limited Manufacturer
Formatting Criteria Teriparatide Biotech 20mcg/80µL solution
Single Page Dimensions
Number of Pages
Font Style
180 (W) x 560 (H)
Frutiger LT Std
18 pt
10 pt
9 pt
